Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells

Clinical trial NCT02638714 · UNKNOWN

Trial details

NCT number: NCT02638714
Sponsor: Stem Cells Arabia
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Optic Neuropathy

Start date: 2013-04-01
Primary completion: 2021-09-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.